Active Ingredient: AZACITIDINE
Proprietary Name: AZACITIDINE
Dosage Form; Route of Administration: POWDER; INTRAVENOUS, SUBCUTANEOUS
Strength: 100MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A209540
Product Number: 001
Approval Date: May 4, 2018
Applicant Holder Full Name: CIPLA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information